PHS
ALDR
PFM Health Sciences’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,306,367
| Closed | -$31.5M | – | 104 |
|
|
2019
Q1 | $31.5M | Buy |
+2,306,367
| New | +$31.5M | 0.7% | 47 |
|
|
2018
Q4 | – | Sell |
-1,916,664
| Closed | -$31.9M | – | 132 |
|
|
2018
Q3 | $31.9M | Sell |
1,916,664
-289,249
| -13% | -$4.82M | 0.47% | 70 |
|
|
2018
Q2 | $34.9M | Sell |
2,205,913
-290,914
| -12% | -$4.6M | 0.55% | 63 |
|
|
2018
Q1 | $31.7M | Buy |
+2,496,827
| New | +$31.7M | 0.64% | 56 |
|
|
2017
Q3 | – | Sell |
-834,191
| Closed | -$9.55M | – | 100 |
|
|
2017
Q2 | $9.55M | Sell |
834,191
-210,990
| -20% | -$2.42M | 0.26% | 76 |
|
|
2017
Q1 | $21.7M | Sell |
1,045,181
-1,868,770
| -64% | -$38.9M | 0.54% | 60 |
|
|
2016
Q4 | $60.6M | Buy |
2,913,951
+906,287
| +45% | +$18.9M | 1.71% | 17 |
|
|
2016
Q3 | $65.8M | Sell |
2,007,664
-1,891,545
| -49% | -$62M | 1.93% | 17 |
|
|
2016
Q2 | $97.4M | Buy |
3,899,209
+356,562
| +10% | +$8.9M | 2.94% | 3 |
|
|
2016
Q1 | $86.8M | Buy |
3,542,647
+1,652,617
| +87% | +$40.5M | 2.68% | 8 |
|
|
2015
Q4 | $62.4M | Buy |
1,890,030
+784,119
| +71% | +$25.9M | 1.9% | 20 |
|
|
2015
Q3 | $36.2M | Buy |
1,105,911
+352,630
| +47% | +$11.6M | 1.02% | 37 |
|
|
2015
Q2 | $39.9M | Buy |
753,281
+122,815
| +19% | +$6.51M | 1.01% | 40 |
|
|
2015
Q1 | $18.2M | Buy |
630,466
+300,518
| +91% | +$8.67M | 0.5% | 61 |
|
|
2014
Q4 | $9.6M | Sell |
329,948
-704,082
| -68% | -$20.5M | 0.22% | 75 |
|
|
2014
Q3 | $13.1M | Buy |
1,034,030
+296,003
| +40% | +$3.75M | 0.3% | 49 |
|
|
2014
Q2 | $14.8M | Buy |
+738,027
| New | +$14.8M | 0.3% | 55 |
|